chitosan has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, A; Luo, T; Ma, Y; Rao, L; Wang, Y; Zhuang, M | 1 |
| Bitar, KN; Elbahrawy, M; Orlando, G; Zakhem, E | 1 |
2 other study(ies) available for chitosan and vasoactive intestinal peptide
| Article | Year |
|---|---|
Chitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitus.
Topics: Animals; Chitosan; Diabetes Mellitus, Type 2; Drug Carriers; Drug Stability; Half-Life; Mice; Nanoparticles; Particle Size; Peptide Fragments; Selenium; Vasoactive Intestinal Peptide | 2014 |
Successful implantation of an engineered tubular neuromuscular tissue composed of human cells and chitosan scaffold.
Topics: Animals; Cells, Cultured; Chitosan; Electric Stimulation; Enteric Nervous System; Heterografts; Humans; Models, Animal; Muscle Development; Muscle, Smooth; Neurogenesis; Rats; Rats, Nude; Stem Cells; Tetrodotoxin; Tissue Engineering; Tissue Scaffolds; Tissue Transplantation; Vasoactive Intestinal Peptide; Vasodilation | 2015 |